The Competition Commission of India has reportedly stepped up scrutiny of the proposed merger between Sun Pharmaceutical Industries and Ranbaxy Laboratories.

The CCI is said to have approached the companies asking they the authority shouldn’t launch an investigation; the regulator also reportedly said the merger would result in significant market strength …read more

Source: Global Competition Law Blogs